EN HU
logo Tudóstér

Emri Gabriella

Emri Gabriella
University of Debrecen Faculty of Medicine
Department of Dermatology

Publication list

Tudóstér co-authors statistics filterable publication list
Uploaded publications:
123
Publications in DEA:
122
OA:
69
Date range:
1998-2024
2024
1.
Chang Chien, Y. C., Mokánszki, A., Kollár, S., Méhes, G., Emri, G.: A PRAME diagnosztikai jelentősége Clear Cell Sarcomában: Esetismertetés.
Bőrgyógyász. venerol. szle. 100 (5), 241-245, 2024.
doi DEA
2.
De Smedt, J., Aura, C., Van Kelst, S., Janssen, L., Marasigan, V., Boecxstaens, V., Stas, M., Bogaerts, K., Belmans, A., Cleynen, I., Vanderschueren, D., Vandenberghe, K., Bechter, O., Nikkels, A., Strobbe, T., Emri, G., Lambrechts, D., Garmyn, M.: Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.
Melanoma Res. 34 (2), 125-133, 2024.
doi DEA Scopus
Journal metrics:
Q3 Cancer Research (2023)
Q2 Dermatology (2023)
Q3 Oncology (2023)
3.
Várvölgyi, T., Janka, E. A., Szász, I., Koroknai, V., Toka-Farkas, T., Szabó, I. L., Ványai, B., Szegedi, A., Emri, G., Balázs, M.: Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
J Clin Med. 13 (1), 1-13, (article identifier: 174), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Medicine (miscellaneous) (2023)
4.
Tári, V., Janka, E. A., Emri, G., Nemes, B. Á., Remenyik, É., Gellén, E.: Effect of education on sun-safe behaviour in kidney transplant recipients.
Photodermatol. Photoimmunol. Photomed. 40 (3), 1-8, (article identifier: 12966), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Dermatology (2023)
Q3 Immunology (2023)
Q3 Immunology and Allergy (2023)
Q2 Medicine (miscellaneous) (2023)
Q2 Radiology, Nuclear Medicine and Imaging (2023)
5.
Szász, I., Koroknai, V., Várvölgyi, T., Pál, L., Szűcs, S., Pikó, P., Emri, G., Janka, E. A., Szabó, I. L., Ádány, R., Balázs, M.: Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.
Int. J. Mol. Sci. 25 (8), 1-15, (article identifier: 4251), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)
6.
Janka, E. A., Szabó, I. L., Kollár, S., Toka-Farkas, T., Ványai, B., Várvölgyi, T., Kapitány, A., Shabu, H., Szegedi, A., Emri, G.: Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors.
Cancers (Basel). 16, 1-18, (article identifier: 2981), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research (2023)
Q1 Oncology (2023)
2023
7.
Palatka, R., Janka, E. A., Soltész, L., Szabó, I. L., Kapitány, A., Dajnoki, Z., Emri, G., Nagy, G., Palatka, K., Zouboulis, C. C., Szegedi, A., Gáspár, K.: Chronic inflammatory intestinal disorders in hidradenitis suppurativa.
Dermatology. 239 (4), 592-600, 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Dermatology
8.
Csoma, S. L., Madarász, K., Chang Chien, Y. C., Emri, G., Bedekovics, J., Méhes, G., Mokánszki, A.: Correlation Analyses between Histological Staging and Molecular Alterations in Tumor-Derived and Cell-Free DNA of Early-Stage Primary Cutaneous Melanoma.
Cancers (Basel). 15 (21), 1-13, (article identifier: 5141), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
9.
Erdei, A., Ménes, E., Emri, G.: Endocrine side effects of immune-checkpoint inhibitors in patients with malignant melanoma.
Endocrine Abstracts. 90, EP678, 2023.
doi DEA
10.
Ványai, B., Szabó, I. L., Veres, I., Soltész, L., Várvölgyi, T., Emri, G.: Lentigo maligna melanoma.
Bőrgyógyász. venerol. szle. 99 (4), 293-297, 2023.
doi DEA
11.
Janka, E. A., Ványai, B., Szabó, I. L., Toka-Farkas, T., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
Front Oncol. 13, 1-11, (article identifier: 1237643), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q2 Oncology
12.
Liszkay, G., Benedek, A., Polgár, C., Oláh, J., Holló, P., Emri, G., Csejtei, A., Kenessey, I., Polányi, Z., Knollmajer, K., Várnai, M., Vokó, Z., Nagy, B., Rokszin, G., Fábián, I., Barcza, Z., Gyulai, R., Kiss, Z.: Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019.
J. Eur. Acad. Dermatol. Venereol. 37 (5), 932-940, 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Dermatology
D1 Infectious Diseases
2022
13.
Ványai, B., Chien, Y. C. C., Beke, L., Szabó, I. L., Péter, Z., Steuer-Hajdu, K., Várvölgyi, T., Méhes, G., Emri, G.: Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanoma.
Immunotherapy. 14 (17), 1377-1382, 2022.
doi DEA WoS Scopus
Journal metrics:
Q3 Immunology
Q2 Immunology and Allergy
Q2 Oncology
14.
De Smedt, J., Van Kelst, S., Janssen, L., Marasigan, V., Boecxstaens, V., Stas, M., Vanderschueren, D., Guler, I., Bogaerts, K., Vandenberghe, K., Bechter, O., Billen, J., Nikkels, A., Strobbe, T., Emri, G., Lambrechts, D., Garmyn, M.: Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population.
Acta Derm.-Venereol. 102, 1-7, (article identifier: 00692), 2022.
doi DEA WoS Scopus
Journal metrics:
Q1 Dermatology
Q1 Medicine (miscellaneous)
15.
Vanickova, L., Do, T., Vejvodová, M., Horák, V., Hubálek, M., Emri, G., Zemánková, K., Pavelicová, K., Krizkova, S., Faltusová, V., Pompeiano, A., Vaculovičová, M., Zitka, O., Vaculovič, T., Adam, V.: Mapping of MeLiM melanoma combining ICP-MS and MALDI-MSI methods.
Int. J. Biol. Macromol. 203, 583-592, 2022.
doi DEA WoS Scopus
Journal metrics:
Q1 Biochemistry
Q1 Economics and Econometrics
Q1 Energy (miscellaneous)
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q2 Structural Biology
16.
Ding, L., Gosh, A., Lee, D. J., Emri, G., Huss, W. J., Bogner, P. N., Paragh, G. J.: Prognostic biomarkers of cutaneous melanoma.
Photodermatol. Photoimmunol. Photomed. 38 (5), 418-434, 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Dermatology
Q3 Immunology
Q3 Immunology and Allergy
Q2 Medicine (miscellaneous)
Q2 Radiology, Nuclear Medicine and Imaging
17.
Janka, E. A., Ványai, B., Dajnoki, Z., Szabó, I. L., Reibl, D., Komka, I., Blasszauer, C., Várvölgyi, T., Szegedi, A., Emri, G.: Regional variability of melanoma incidence and prevalence in Hungary. Epidemiological impact of ambient UV radiation and socioeconomic factors.
Eur. J. Cancer Prev. 31 (4), 377-384, 2022.
doi DEA WoS Scopus
Journal metrics:
Q3 Cancer Research
Q3 Epidemiology
Q3 Oncology
Q2 Public Health, Environmental and Occupational Health
2021
18.
Liszkay, G., Kiss, Z., Gyulai, R., Oláh, J., Holló, P., Emri, G., Csejtei, A., Kenessey, I., Benedek, A., Polányi, Z., Nagy-Erdei, Z., Daniel, A., Knollmajer, K., Várnai, M., Vokó, Z., Nagy, B., Rokszin, G., Fábián, I., Barcza, Z., Polgár, C.: Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: a Nationwide Epidemiological Study.
Front Oncol. 10, 1-10, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
19.
Hegedűs, C., Juhász, T., Fidrus, E., Janka, E. A., Juhász, G., Boros, G., Paragh, G. J., Uray, K., Emri, G., Remenyik, É., Bai, P.: Cyclobutane pyrimidine dimers from UVB exposure induce a hypermetabolic state in keratinocytes via mitochondrial oxidative stress.
Redox Biol. 38, 1-17, 2021.
DEA WoS Scopus
Journal metrics:
D1 Biochemistry
D1 Clinical Biochemistry
D1 Organic Chemistry
20.
Várnai, M., Kiss, Z., Gyulai, R., Oláh, J., Holló, P., Emri, G., Csejtei, A., Kenessey, I., Benedek, A., Polányi, Z., Nagy-Erdei, Z., Daniel, A., Knollmajer, K., Rokszin, G., Fábián, I., Barcza, Z., Polgár, C., Nagy, B., Liszkay, G., Vokó, Z.: Improving Quality Indicator of Melanoma Management - Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study.
Front Oncol. 11, 1-10, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
21.
Fidrus, E., Hegedűs, C., Janka, E. A., Paragh, G., Emri, G., Remenyik, É.: Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis - an In Vitro Study.
Int. J. Mol. Sci. 22 (4), 1-17, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
22.
Hajdú, T., Kovács, P., Zsigrai, E., Takács, R. Á., Vágó, J., Cho, S., Sasi Szabó, L. A., Becsky, D., Keller-Pintér, A., Emri, G., Rácz, K., Reglődi, D., Zákány, R., Juhász, T.: Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro.
Front Oncol. 11, 681603, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
23.
Janka, E. A., Várvölgyi, T., Sipos, Z., Soós, A., Hegyi, P. J., Kiss, S., Dembrovszky, F., Csupor, D., Kéringer, P., Pécsi, D., Solymár, M., Emri, G.: Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: a Systematic Review and Meta-Analysis.
Front Oncol. 11, 1-11, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
2020
24.
Kolozsvári, B. L., Emri, G., Csonka, T., Tönköl, T., Fodor, M.: A szemhéjtumorok eltávolítása és kezelése.
Szemészet. 157 (2), 94-102, 2020.
DEA
25.
Emri, G.: Dermatoszkópiai alapfogalmak.
In: Gyermekbőrgyógyászat. Szerk.: Szalai Zsuzsanna, Medicina Könyvkiadó Zrt., Budapest, 207-212, 2020.
DEA
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.